New Market Research Report: Bangladesh Pharmaceuticals & Healthcare Report Q4 2014

From: Fast Market Research, Inc.
Published: Fri Oct 17 2014


We consider Bangladesh 's commitment to another round of spending on the development of healthcare, information technology, infrastructure, energy production, education, agriculture and food security and transportation in fiscal year 2014/2015 as a sound investment. While we are optimistic that ongoing tax reform efforts by the government will rake in more revenues to support development spending, and keep the country's budget deficit manageable at around 3. 0% of GDP over the coming years, the lack of government revenues remains a major obstacle to Bangladesh's economic development and may delay much-needed investments in improving the population's access to healthcare.

Headline Expenditure Projections

* Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.74bn (USD1.99bn) in 2014; +11.5% in local currency terms and +12.1% in US dollar terms
* Healthcare: BDT375.52bn (USD4.81bn) in 2013 to BDT419.78bn (USD5.41bn) in 2014; +11.8% in local currency terms and +12.4% in US dollar terms

Full Report Details at
- http://www.fastmr.com/prod/878936_bangladesh_pharmaceuticals_healthcare_report_q4.aspx?afid=302

Risk/Reward Ratings: While geographic diversification and investment into the pharmaceutical and healthcare sectors of emerging economies such as Bangladesh may be a favourable strategy for any multinational pharmaceutical company, it is vital that a company recognises both the rewards and the risks present in a market. In Q414, Bangladesh stands at 16th position out of the 19 regional markets surveyed. Its overall rating of 40.2 out of 100 remains considerably below the average for the region.

Key Trends And Developments

Highlighting a challenging condition for drugmakers operating in Bangladesh, analysis published in the BMC in February 2014, showed that the use of traditional medicines has increased among community members of all socio-economic and demographic backgrounds. Due to the increased incidence of disease and sickness respondents are forced to increase the use of their cultural means to cope with adverse health situations.

The government of...

The Bangladesh Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Bangladesh Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Bangladeshi pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's independent pharmaceutical and healthcare industry forecasts for Bangladesh to test other views - a key input for successful budgeting and strategic business planning in the Bangladeshi pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- South Korea Pharmaceuticals & Healthcare Report Q4 2014
- Sweden Pharmaceuticals & Healthcare Report Q4 2014
- Kenya Pharmaceuticals & Healthcare Report Q4 2014
- Argentina Pharmaceuticals & Healthcare Report Q4 2014
- Peru Pharmaceuticals & Healthcare Report Q4 2014

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »